Clinical case of infertility treatment and pregnancy and delivery management following uterine artery embolization for uterine fibroids



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Uterine artery embolization is a minimally invasive and effective method for treating symptomatic uterine fibroids; however, its impact on fertility, pregnancy course, and obstetric outcomes remains a topic of ongoing debate.

This article presents a clinical case involving the management of a patient with infertility due to uterine factors following uterine artery embolization, which was complicated by non-target embolization of the ovarian vessels. After specialized laser spectral diagnostics of endometrial status and restorative treatment, the patient achieved a spontaneous pregnancy. The pregnancy was complicated by the threat of miscarriage, cervical insufficiency, premature detachment of a normally located placenta, and preterm delivery at 32–33 weeks, as well as prolonged postpartum vaginal bleeding.

Additional studies are needed to investigate long-term reproductive outcomes in women following uterine artery embolization and to develop diagnostic and preventive approaches aimed at reducing the risk of complications. The results of this study may contribute to improving the management strategies for patients with similar complications and serve as a basis for developing treatment guidelines.

Full Text

Restricted Access

About the authors

Vladimir M. Zuev

I.M. Sechenov First Moscow State Medical University; ART-ECO Reproductive Health Clinic

Author for correspondence.
Email: vlzuev@bk.ru
ORCID iD: 0000-0001-8715-2020
SPIN-code: 2857-0309

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Moscow; Moscow

Olga I. Lisitsyna

ART-ECO Reproductive Health Clinic

Email: o_yazykova@inbox.ru
ORCID iD: 0000-0002-7775-3508
SPIN-code: 5211-4258
Russian Federation, Moscow

Elena А. Kalinina

ART-ECO Reproductive Health Clinic

Email: kalinina@art-ivf.ru
ORCID iD: 0000-0002-1273-8358

MD, Dr. Sci. (Medicine)

Russian Federation, Moscow

Nataliya V. Goncharenko

I.M. Sechenov First Moscow State Medical University; ART-ECO Reproductive Health Clinic

Email: goncharenko_n_v@staff.sechenov.ru
ORCID iD: 0000-0003-2925-1260
Russian Federation, Moscow; Moscow

Andrey V. Murashko

I.M. Sechenov First Moscow State Medical University

Email: murashkoa@mail.ru
ORCID iD: 0000-0003-0663-2909
SPIN-code: 2841-9638

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Moscow

Tea A. Dzhibladze

I.M. Sechenov First Moscow State Medical University; ART-ECO Reproductive Health Clinic

Email: djiba@bk.ru
ORCID iD: 0000-0003-1540-5628
SPIN-code: 5688-1084

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Moscow; Moscow

Irina D. Khokhlova

I.M. Sechenov First Moscow State Medical University

Email: irhohlova5@gmail.com
ORCID iD: 0000-0001-8547-6750
SPIN-code: 6858-5235

MD, Cand. Sci. (Medicine), Assistant Professor

Russian Federation, Moscow

Dmitrii V. Baburin

I.M. Sechenov First Moscow State Medical University

Email: baburin_d_v@staff.sechenov.ru
ORCID iD: 0000-0003-2398-3348
SPIN-code: 3264-0730

MD, Cand. Sci. (Medicine)

Russian Federation, Moscow

References

  1. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstet Gynecol. 2021;137(6):e100–e115. doi: 10.1097/AOG.0000000000004401
  2. Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–107. doi: 10.1067/mob.2003.99
  3. Kubik-Huch RA, Weston M, Nougaret S, et al. European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas. Eur Radiol. 2018;28(8):3125–3137. doi: 10.1007/s00330-017-5157-5
  4. Mas A, Tarazona M, Dasí Carrasco J, et al. Updated approaches for management of uterine fibroids. Int J Womens Health. 2017;9:607–617. doi: 10.2147/IJWH.S138982
  5. Czuczwar P, Stepniak A, Milart P, et al. Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve — an observational study. J Ovarian Res. 2018;11(1):45. doi: 10.1186/s13048-018-0420-1
  6. Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril. 2010;94(1):324–330. doi: 10.1016/j.fertnstert.2009.02.069
  7. Mara M, Maskova J, Fucikova Z, et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol. 2008;31(1):73–85. doi: 10.1007/s00270-007-9195-2
  8. Zanolli NC, Bishop KC, Kuller JA, et al. Fibroids and fertility: a comparison of myomectomy and uterine artery embolization on fertility and reproductive outcomes. Obstet Gynecol Surv. 2022;77(8):485–494. doi: 10.1097/OGX.0000000000001052
  9. Goldberg J, Pereira L, Berghella V, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol. 2004;191(1):18–21. doi: 10.1016/j.ajog.2004.01.046
  10. Ziganshin AM, Dikke GB, Yanbarisova AR, et al. Experience of managing pregnancy after in vitro fertilization and its outcome in a patient with uterine leiomyoma and a history of uterine artery embolization. Obstetrics and Gynecology. 2024;(11):229–234. doi: 10.18565/aig.2024.275 EDN: BSXJVB
  11. Savelyeva GM, Krasnova IA, Breusenko VG, et al. The efficiency of EMA and prevention of its possible complications in the treatment of myoma. Obstetrics and Gynecology. 2014;(11):74–79. EDN: TAZJTR
  12. Kalmykov EL, Rakhimov FR, Umarzoda SG, Baratov AK. Uterine artery embolization for uterine leiomyoma: the state of the problem. Obstetrics and Gynecology. 2020;(9):18–26. doi: 10.18565/aig.2020.9.18-26 EDN: SLPJDJ
  13. Zuev VM, Kalinina EA, Kukushkin VI, et al. Innovative laser technologies in the diagnosis and treatment of the endometrium of concern in reproductive medicine. Obstetrics and Gynecology. 2020;(4):157–165. doi: 10.18565/aig.2020.4.157-165 EDN: IQOFPF
  14. Ravina JH, Ciraru-Vigneron N, Bouret JM, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346(8976):671–672. doi: 10.1016/S0140-6736(95)92282-2
  15. Ryu RK, Chrisman HB, Omary RA, et al. The vascular impact of uterine artery embolization: prospective sonographic assessment of ovarian arterial circulation. J Vasc Interv Radiol. 2001;12(9):1071–1074. doi: 10.1016/S1051-0443(07)61594-2
  16. Kaump GR, Spies JB. The impact of uterine artery embolization on ovarian function. J Vasc Interv Radiol. 2013;24(4):459–467. doi: 10.1016/j.jvir.2012.12.002
  17. Amato P, Roberts AC. Transient ovarian failure: a complication of uterine artery embolization. Fertil Steril. 2001;75(2):438–439. doi: 10.1016/s0015-0282(00)01678-2
  18. Wolanske KA, Gordon RL, Wilson MW, et al. Coil embolization of a tuboovarian anastomosis before uterine artery embolization to prevent nontarget particle embolization of the ovary. J Vasc Interv Radiol. 2003;14(10):1333–1338. doi: 10.1097/01.RVI.0000092906.31640
  19. Liu J-L, Liang Z-H, Cui B, et al. Impact of uterine artery embolization on ovarian function and pregnancy outcome after uterine-fibroids treatment: A prospective study. World J Clin Cases. 2024;12(15):2551–2559. doi: 10.12998/wjcc.v12.i15.2551
  20. El Shamy T, Amer SAK, Mohamed AA, et al. The impact of uterine artery embolization on ovarian reserve: A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2020;99(1):16–23. doi: 10.1111/aogs.13698
  21. Tropeano G, Litwicka K, Di Stasi C, et al. Permanent amenorrhea associated with endometrial atrophy after uterine artery embolization for symptomatic uterine fibroids. Fertil Steril. 2003;79(1):132–135. doi: 10.1016/S0015-0282(02)04400-X
  22. Peng J, Wang J, Shu Q, et al. Systematic review and meta-analysis of current evidence in uterine artery embolization vs myomectomy for symptomatic uterine fibroids. Sci Rep. 2024;14(1):19252. doi: 10.1038/s41598-024-69754-0
  23. Dzhibladze TA, Zuev VM, Ishchenko AI, et al. Complication treatment for uterine factor infertility in Asherman’s syndrome. Obstetrics and Gynecology. 2022;(3):165–169. doi: 10.18565/aig.2022.3.165-169 EDN: NJKLKW
  24. Fang Z, Huang J, Mao J, et al. Effect of endometrial thickness on obstetric and neonatal outcomes in assisted reproduction: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2023;21(1):55. doi: 10.1186/s12958-023-01105-6
  25. Choo S, Wiseman D, MacMillan JB, Gratton R. Myometrial defect in a subsequent pregnancy after uterine artery embolization for postpartum hemorrhage, in the absence of leiomyomas or previous uterine surgery. J Obstet Gynaecol Can. 2020;42(2):173–176. doi: 10.1016/j.jogc.2019.04.013
  26. Yan X, Zhou L, He G, Liu X. Pregnancy rate and outcomes after uterine artery embolization for women: a systematic review and meta-analysis with trial sequential analysis. Front Med (Lausanne). 2023;10:1283279. doi: 10.3389/fmed.2023.1283279

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Ultrasound of the uterus during the patient’s first visit.

Download (326KB)
Indexing metadata
3. Fig. 2. View of the uterine cavity during office hysteroscopy.

Download (226KB)
Indexing metadata
4. Fig. 3. View of the uterine cavity after the birth of the fetus and removal of the placenta (a section of the cavity devoid of endometrium is visible).

Download (673KB)
Indexing metadata
5. Fig. 4. Ultrasound of the uterus 11 weeks after birth.

Download (270KB)
Indexing metadata

Copyright (c) Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 86335 от 11.12.2023 г.  
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ЭЛ № ФС 77 - 80633 от 15.03.2021 г.